Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection

RATIONALEThe β2-adrenoceptor (β2-AR), a prototypical GPCR (G protein-coupled receptor), couples to both Gs and Gi proteins. Stimulation of the β2-AR is beneficial to humans and animals with heart failure presumably because it activates the downstream Gi-PI3K-Akt cell survival pathway. Cardiac β2-AR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation research 2021-01, Vol.128 (2), p.262-277
Hauptverfasser: Song, Ying, Xu, Chanjuan, Liu, Jianfeng, Li, Yulong, Wang, Huan, Shan, Dan, Wainer, Irving W., Hu, Xinli, Zhang, Yan, Woo, Anthony Yiu-Ho, Xiao, Rui-Ping
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 277
container_issue 2
container_start_page 262
container_title Circulation research
container_volume 128
creator Song, Ying
Xu, Chanjuan
Liu, Jianfeng
Li, Yulong
Wang, Huan
Shan, Dan
Wainer, Irving W.
Hu, Xinli
Zhang, Yan
Woo, Anthony Yiu-Ho
Xiao, Rui-Ping
description RATIONALEThe β2-adrenoceptor (β2-AR), a prototypical GPCR (G protein-coupled receptor), couples to both Gs and Gi proteins. Stimulation of the β2-AR is beneficial to humans and animals with heart failure presumably because it activates the downstream Gi-PI3K-Akt cell survival pathway. Cardiac β2-AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated.OBJECTIVEHere, we aim to investigate the potential cardioprotective effect of β2-adrenergic stimulation with a subtype-selective agonist, (R,R')-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β2-ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT2BRs).METHODS AND RESULTSUsing pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β2-agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin, hydrogen peroxide (H2O2) or ischemia/reperfusion. In doxorubicin (Dox)-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H2O2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β2-agonist zinterol markedly promoted heterodimerization of β2-ARs with 5-HT2BRs. Upregulation of the heterodimerized 5-HT2BRs and β2-ARs enhanced β2-AR-stimulated Gi-Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HT2BR attenuated β2-AR-stimulated Gi signaling and cardioprotection.CONCLUSIONSThese data demonstrate that the β2-AR-stimulated cardioprotective Gi signaling depends on the heterodimerization of β2-ARs and 5-HT2BRs.
doi_str_mv 10.1161/CIRCRESAHA.120.317011
format Article
fullrecord <record><control><sourceid>proquest_wolte</sourceid><recordid>TN_cdi_proquest_miscellaneous_2462408780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2462408780</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1483-af53c2a6f0a866c1305b94e0aed30dd08935b54d8cc8dec1891165ffae569bf73</originalsourceid><addsrcrecordid>eNotkN1Kw0AUhBdRsFYfQcilN1vP2Z_8XMagJlARYsXLsMme0NW0qdmUgo_lg_hMRurVwDB8wwxj1wgLxBBvs6LMyvuXNE8XKGAhMQLEEzZDLRRXOsJTNgOAhEdSwjm78P4dAJUUyYytchpp6K3b0OC-zOj6bfDmxnWgeb4Sd2VQ-KDYWud3tPWm7iho-yH4-RZpyZ_IOjOSDTIzWNfvhn6k5o9wyc5a03m6-tc5e324X2U5Xz4_Flm65DtUseSm1bIRJmzBxGHYoARdJ4rAkJVgLcSJ1LVWNm6a2FKDcTLN1W1rSIdJ3UZyzm6O3Kn6c09-rDbON9R1Zkv93ldChUJBHMUwRdUxeui7abD_6PYHGqo1mW5cV9M7IAEFFyBwUgF8clDKX9ihZcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2462408780</pqid></control><display><type>article</type><title>Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection</title><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Song, Ying ; Xu, Chanjuan ; Liu, Jianfeng ; Li, Yulong ; Wang, Huan ; Shan, Dan ; Wainer, Irving W. ; Hu, Xinli ; Zhang, Yan ; Woo, Anthony Yiu-Ho ; Xiao, Rui-Ping</creator><creatorcontrib>Song, Ying ; Xu, Chanjuan ; Liu, Jianfeng ; Li, Yulong ; Wang, Huan ; Shan, Dan ; Wainer, Irving W. ; Hu, Xinli ; Zhang, Yan ; Woo, Anthony Yiu-Ho ; Xiao, Rui-Ping</creatorcontrib><description>RATIONALEThe β2-adrenoceptor (β2-AR), a prototypical GPCR (G protein-coupled receptor), couples to both Gs and Gi proteins. Stimulation of the β2-AR is beneficial to humans and animals with heart failure presumably because it activates the downstream Gi-PI3K-Akt cell survival pathway. Cardiac β2-AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated.OBJECTIVEHere, we aim to investigate the potential cardioprotective effect of β2-adrenergic stimulation with a subtype-selective agonist, (R,R')-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β2-ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT2BRs).METHODS AND RESULTSUsing pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β2-agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin, hydrogen peroxide (H2O2) or ischemia/reperfusion. In doxorubicin (Dox)-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H2O2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β2-agonist zinterol markedly promoted heterodimerization of β2-ARs with 5-HT2BRs. Upregulation of the heterodimerized 5-HT2BRs and β2-ARs enhanced β2-AR-stimulated Gi-Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HT2BR attenuated β2-AR-stimulated Gi signaling and cardioprotection.CONCLUSIONSThese data demonstrate that the β2-AR-stimulated cardioprotective Gi signaling depends on the heterodimerization of β2-ARs and 5-HT2BRs.</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/CIRCRESAHA.120.317011</identifier><language>eng</language><publisher>Lippincott Williams &amp; Wilkins</publisher><ispartof>Circulation research, 2021-01, Vol.128 (2), p.262-277</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Song, Ying</creatorcontrib><creatorcontrib>Xu, Chanjuan</creatorcontrib><creatorcontrib>Liu, Jianfeng</creatorcontrib><creatorcontrib>Li, Yulong</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Shan, Dan</creatorcontrib><creatorcontrib>Wainer, Irving W.</creatorcontrib><creatorcontrib>Hu, Xinli</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Woo, Anthony Yiu-Ho</creatorcontrib><creatorcontrib>Xiao, Rui-Ping</creatorcontrib><title>Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection</title><title>Circulation research</title><description>RATIONALEThe β2-adrenoceptor (β2-AR), a prototypical GPCR (G protein-coupled receptor), couples to both Gs and Gi proteins. Stimulation of the β2-AR is beneficial to humans and animals with heart failure presumably because it activates the downstream Gi-PI3K-Akt cell survival pathway. Cardiac β2-AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated.OBJECTIVEHere, we aim to investigate the potential cardioprotective effect of β2-adrenergic stimulation with a subtype-selective agonist, (R,R')-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β2-ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT2BRs).METHODS AND RESULTSUsing pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β2-agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin, hydrogen peroxide (H2O2) or ischemia/reperfusion. In doxorubicin (Dox)-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H2O2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β2-agonist zinterol markedly promoted heterodimerization of β2-ARs with 5-HT2BRs. Upregulation of the heterodimerized 5-HT2BRs and β2-ARs enhanced β2-AR-stimulated Gi-Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HT2BR attenuated β2-AR-stimulated Gi signaling and cardioprotection.CONCLUSIONSThese data demonstrate that the β2-AR-stimulated cardioprotective Gi signaling depends on the heterodimerization of β2-ARs and 5-HT2BRs.</description><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkN1Kw0AUhBdRsFYfQcilN1vP2Z_8XMagJlARYsXLsMme0NW0qdmUgo_lg_hMRurVwDB8wwxj1wgLxBBvs6LMyvuXNE8XKGAhMQLEEzZDLRRXOsJTNgOAhEdSwjm78P4dAJUUyYytchpp6K3b0OC-zOj6bfDmxnWgeb4Sd2VQ-KDYWud3tPWm7iho-yH4-RZpyZ_IOjOSDTIzWNfvhn6k5o9wyc5a03m6-tc5e324X2U5Xz4_Flm65DtUseSm1bIRJmzBxGHYoARdJ4rAkJVgLcSJ1LVWNm6a2FKDcTLN1W1rSIdJ3UZyzm6O3Kn6c09-rDbON9R1Zkv93ldChUJBHMUwRdUxeui7abD_6PYHGqo1mW5cV9M7IAEFFyBwUgF8clDKX9ihZcA</recordid><startdate>20210122</startdate><enddate>20210122</enddate><creator>Song, Ying</creator><creator>Xu, Chanjuan</creator><creator>Liu, Jianfeng</creator><creator>Li, Yulong</creator><creator>Wang, Huan</creator><creator>Shan, Dan</creator><creator>Wainer, Irving W.</creator><creator>Hu, Xinli</creator><creator>Zhang, Yan</creator><creator>Woo, Anthony Yiu-Ho</creator><creator>Xiao, Rui-Ping</creator><general>Lippincott Williams &amp; Wilkins</general><scope>7X8</scope></search><sort><creationdate>20210122</creationdate><title>Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection</title><author>Song, Ying ; Xu, Chanjuan ; Liu, Jianfeng ; Li, Yulong ; Wang, Huan ; Shan, Dan ; Wainer, Irving W. ; Hu, Xinli ; Zhang, Yan ; Woo, Anthony Yiu-Ho ; Xiao, Rui-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1483-af53c2a6f0a866c1305b94e0aed30dd08935b54d8cc8dec1891165ffae569bf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Ying</creatorcontrib><creatorcontrib>Xu, Chanjuan</creatorcontrib><creatorcontrib>Liu, Jianfeng</creatorcontrib><creatorcontrib>Li, Yulong</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Shan, Dan</creatorcontrib><creatorcontrib>Wainer, Irving W.</creatorcontrib><creatorcontrib>Hu, Xinli</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Woo, Anthony Yiu-Ho</creatorcontrib><creatorcontrib>Xiao, Rui-Ping</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Ying</au><au>Xu, Chanjuan</au><au>Liu, Jianfeng</au><au>Li, Yulong</au><au>Wang, Huan</au><au>Shan, Dan</au><au>Wainer, Irving W.</au><au>Hu, Xinli</au><au>Zhang, Yan</au><au>Woo, Anthony Yiu-Ho</au><au>Xiao, Rui-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection</atitle><jtitle>Circulation research</jtitle><date>2021-01-22</date><risdate>2021</risdate><volume>128</volume><issue>2</issue><spage>262</spage><epage>277</epage><pages>262-277</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><abstract>RATIONALEThe β2-adrenoceptor (β2-AR), a prototypical GPCR (G protein-coupled receptor), couples to both Gs and Gi proteins. Stimulation of the β2-AR is beneficial to humans and animals with heart failure presumably because it activates the downstream Gi-PI3K-Akt cell survival pathway. Cardiac β2-AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated.OBJECTIVEHere, we aim to investigate the potential cardioprotective effect of β2-adrenergic stimulation with a subtype-selective agonist, (R,R')-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β2-ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT2BRs).METHODS AND RESULTSUsing pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β2-agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin, hydrogen peroxide (H2O2) or ischemia/reperfusion. In doxorubicin (Dox)-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H2O2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β2-agonist zinterol markedly promoted heterodimerization of β2-ARs with 5-HT2BRs. Upregulation of the heterodimerized 5-HT2BRs and β2-ARs enhanced β2-AR-stimulated Gi-Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HT2BR attenuated β2-AR-stimulated Gi signaling and cardioprotection.CONCLUSIONSThese data demonstrate that the β2-AR-stimulated cardioprotective Gi signaling depends on the heterodimerization of β2-ARs and 5-HT2BRs.</abstract><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1161/CIRCRESAHA.120.317011</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7330
ispartof Circulation research, 2021-01, Vol.128 (2), p.262-277
issn 0009-7330
1524-4571
language eng
recordid cdi_proquest_miscellaneous_2462408780
source American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
title Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated Cardioprotection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T14%3A04%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wolte&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heterodimerization%20With%205-HT2BR%20Is%20Indispensable%20for%20%CE%B22AR-Mediated%20Cardioprotection&rft.jtitle=Circulation%20research&rft.au=Song,%20Ying&rft.date=2021-01-22&rft.volume=128&rft.issue=2&rft.spage=262&rft.epage=277&rft.pages=262-277&rft.issn=0009-7330&rft.eissn=1524-4571&rft_id=info:doi/10.1161/CIRCRESAHA.120.317011&rft_dat=%3Cproquest_wolte%3E2462408780%3C/proquest_wolte%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2462408780&rft_id=info:pmid/&rfr_iscdi=true